SCHEMBL28090702

SCHEMBL28090702

CC(C)(c1ccc(C(F)(F)F)cc1[N+](=O)[O-])[SH](=O)=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.47
ALDH1A1 P00352 5/20 0.46
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
HIF1A Q16665 1/20 0.46
TXNRD1 Q16881 1/20 0.46
TXNRD3 Q86VQ6 1/20 0.46
TXNRD2 Q9NNW7 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 5/20 0.45
GAA P10253 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7039417 0.84 ALDH1A1 (0.51) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL1995690 0.82 ALDH1A1 (0.56) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL29398386 0.82 ALDH1A1 (0.56) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL28832945 0.80 TSHR (0.55) MAPK1ALDH1A1CYP3A4TSHRTDP1
SCHEMBL1264392 0.78 MAPK1 (0.46) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL1264694 0.78 MAPK1 (0.46) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL28840504 0.78 ALDH1A1 (0.56) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL1264388 0.75 MAPT (0.46) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL29942185 0.75 ALDH1A1 (0.60) MAPK1ALDH1A1CYP3A4HPGDALOX15
SCHEMBL7240751 0.75 ALDH1A1 (0.60) MAPK1ALDH1A1CYP3A4HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106187915-A There is inhibitor of ALK Yu EGFR double activity and its preparation method and application 上海翰森生物医药科技有限公司 2016-12-07 CN disclosed